BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 16970925)

  • 1. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.
    Dejardin E
    Biochem Pharmacol; 2006 Oct; 72(9):1161-79. PubMed ID: 16970925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide from Salmonella enterica activates NF-kappaB through both classical and alternative pathways in primary B Lymphocytes.
    Souvannavong V; Saidji N; Chaby R
    Infect Immun; 2007 Oct; 75(10):4998-5003. PubMed ID: 17698569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.
    Yilmaz ZB; Weih DS; Sivakumar V; Weih F
    EMBO J; 2003 Jan; 22(1):121-30. PubMed ID: 12505990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
    Xiao G; Rabson AB; Young W; Qing G; Qu Z
    Cytokine Growth Factor Rev; 2006 Aug; 17(4):281-93. PubMed ID: 16793322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.
    Soysa NS; Alles N; Weih D; Lovas A; Mian AH; Shimokawa H; Yasuda H; Weih F; Jimi E; Ohya K; Aoki K
    J Bone Miner Res; 2010 Apr; 25(4):809-18. PubMed ID: 19839765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
    Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
    APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors.
    Remouchamps C; Dejardin E
    Methods Mol Biol; 2015; 1280():103-19. PubMed ID: 25736746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.
    Müller JR; Siebenlist U
    J Biol Chem; 2003 Apr; 278(14):12006-12. PubMed ID: 12556537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
    Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
    Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenes, tumor suppressors and p52 NF-kappaB.
    Perkins ND
    Oncogene; 2003 Oct; 22(48):7553-6. PubMed ID: 14576816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB p52, RelB and c-Rel are transported into the nucleus via a subset of importin alpha molecules.
    Fagerlund R; Melén K; Cao X; Julkunen I
    Cell Signal; 2008 Aug; 20(8):1442-51. PubMed ID: 18462924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
    Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
    Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling to NF-kappaB by Toll-like receptors.
    Kawai T; Akira S
    Trends Mol Med; 2007 Nov; 13(11):460-9. PubMed ID: 18029230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of late B cell differentiation by intrinsic IKKalpha-dependent signals.
    Mills DM; Bonizzi G; Karin M; Rickert RC
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6359-64. PubMed ID: 17404218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models.
    Gerondakis S; Grumont R; Gugasyan R; Wong L; Isomura I; Ho W; Banerjee A
    Oncogene; 2006 Oct; 25(51):6781-99. PubMed ID: 17072328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications.
    Espinosa I; Briones J; Bordes R; Brunet S; Martino R; Sureda A; Sierra J; Prat J
    Histopathology; 2008 Oct; 53(4):441-9. PubMed ID: 18983609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.
    Enzler T; Bonizzi G; Silverman GJ; Otero DC; Widhopf GF; Anzelon-Mills A; Rickert RC; Karin M
    Immunity; 2006 Sep; 25(3):403-15. PubMed ID: 16973390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.